China Shineway Pharmaceutical Group Limited (C1S) — Net Asset Quality Index
China Shineway Pharmaceutical Group Limited (C1S) has a Net Asset Quality Index of 74.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €10.78 Billion minus total liabilities of €2.72 Billion yields net assets of €8.06 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read C1S current and long-term liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
China Shineway Pharmaceutical Group Limited Net Asset Quality Index Over Time (2013–2025)
This chart shows how China Shineway Pharmaceutical Group Limited's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of December 2025, the index stands at 74.8%, representing net assets of €8.06 Billion against total assets of €10.78 Billion EUR. For live market cap and overall valuation, see C1S stock market capitalisation.
Annual Net Asset Quality Index for China Shineway Pharmaceutical Group Limited (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for China Shineway Pharmaceutical Group Limited from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check C1S capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.8% | €8.06 Billion | €10.78 Billion | €2.72 Billion | ▲ +0.4 pp |
| 2024 | 74.4% | €7.47 Billion | €10.04 Billion | €2.57 Billion | ▲ +0.9 pp |
| 2023 | 73.5% | €7.03 Billion | €9.57 Billion | €2.54 Billion | ▼ -4.1 pp |
| 2022 | 77.5% | €6.38 Billion | €8.23 Billion | €1.85 Billion | ▼ -4.4 pp |
| 2021 | 81.9% | €5.90 Billion | €7.20 Billion | €1.30 Billion | ▲ +1.6 pp |
| 2020 | 80.3% | €5.79 Billion | €7.21 Billion | €1.42 Billion | ▼ -0.7 pp |
| 2019 | 81.0% | €5.78 Billion | €7.13 Billion | €1.35 Billion | ▼ -4.6 pp |
| 2018 | 85.7% | €5.77 Billion | €6.73 Billion | €966.01 Million | ▼ -1.7 pp |
| 2017 | 87.3% | €5.82 Billion | €6.67 Billion | €844.16 Million | ▲ +0.3 pp |
| 2016 | 87.0% | €5.63 Billion | €6.47 Billion | €838.59 Million | ▲ +1.0 pp |
| 2015 | 86.1% | €5.30 Billion | €6.15 Billion | €857.13 Million | ▲ +3.2 pp |
| 2014 | 82.8% | €4.89 Billion | €5.91 Billion | €1.01 Billion | ▲ +5.6 pp |
| 2013 | 77.2% | €4.43 Billion | €5.74 Billion | €1.31 Billion | — |